Presence
Worldwide Footprints
Expanding global access through quality-driven pharmaceutical manufacturing.
​
Maxtar Biogenics is steadily building a strong international presence across emerging and semi-regulated markets, with a strategic focus on Latin America, Africa, Asia, and select CIS regions. Our global expansion is driven by a commitment to delivering high-quality, compliant, and affordable pharmaceutical products tailored to diverse market needs.
​
We actively collaborate with international partners for product development, third-party manufacturing, and private labeling, enabling efficient market entry and sustainable growth. Our expertise in regulatory documentation—including CTD and ACTD dossiers, stability studies, and export documentation—ensures seamless registration and commercialization across multiple geographies.
​
With a flexible manufacturing approach and scalable production capabilities, we support our partners in meeting dynamic market demands while maintaining strict adherence to WHO-GMP standards. Our ability to customize formulations, packaging, and documentation as per country-specific requirements positions us as a reliable partner in global pharmaceutical supply.
​
As we continue to expand our footprint, our focus remains on building long-term partnerships, strengthening regulatory capabilities, and contributing to improved healthcare access across international markets.
Domestic Presence
Strengthening healthcare access across India through quality and affordability.
​
Arika Healthcare, a sister concern of Maxtar Biogenics, has been established to cater specifically to the growing demand of the Indian generic pharmaceutical market. Built on the same foundation of quality, compliance, and ethical practices, Arika Healthcare focuses on delivering high-quality, affordable medicines across diverse therapeutic segments.
​
With a strong commitment to patient-centric healthcare, Arika is steadily expanding its presence through strategic partnerships with healthcare professionals, distributors, and institutions across the country. Backed by Maxtar’s WHO-GMP compliant manufacturing capabilities, every product is developed and produced with stringent quality standards and consistency.
As we continue to grow, Arika Healthcare aims to bridge the gap between quality and affordability by making reliable medicines accessible to a wider population. Our domestic strategy is driven by trust, long-term relationships, and a vision to contribute meaningfully to India’s healthcare ecosystem.